201
10
731
1
2
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T12838 | SARS-CoV-IN-2 | Others | |
SARS-CoV-IN-2 is an effective SARS-CoV replication inhibitor | |||
T77516 | SARS-CoV-2-IN-39 | Antiviral , SARS-CoV | |
SARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1. | |||
T77510 | SARS-CoV-2-IN-46 | SARS-CoV | |
SARS-CoV-2-IN-46 is a SARS-CoV-2 inhibitor. | |||
T79455 | SARS-CoV-2 Mpro-IN-9 | SARS-CoV-2 Mpro IN 9,SARS-CoV-2 Mpro-IN 9 | SARS-CoV |
SARS-CoV-2 Mpro-IN-9 (SARS-CoV-2 Mpro IN 9) is a potent SARS-CoV-2 Mpro inhibitor with an IC50 value of 80 nM.SARS-CoV-2 Mpro-IN-9 exhibits antiviral activity and inhibits 3C-like cysteine protease. | |||
T60538 | SARS-CoV-2-IN-14 | 3',5-Dichlorosalicylanilide | SARS-CoV |
SARS-CoV-2-IN-14 is a potent and oral inhibitor of SARS-CoV-2 (IC50:0.39 μM), which is an analogue of niclosamide. SARS-CoV-2-IN-14 was more stable than niclosamide in the determination of human plasma and liver S9 enzym... | |||
T77652 | SARS-CoV-2 3CLpro-IN-20 | Antiviral , SARS-CoV | |
SARS-CoV-2 3CLpro-IN-20 is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 0.43 μM,).SARS-CoV-2 3CLpro-IN-20 has potential antiviral activity. | |||
T40340 | SARS-CoV-2-IN-10 | Others | |
SARS-CoV-2-IN-10 is a powerful and non-toxic inhibitor of SARS-CoV-2 3CL protease, with IC50 and EC50 values of 0.13 nM and 1.03 nM, respectively. The SARS-CoV-2 3C-like protease (3CLpro) is a critical enzyme for viral r... | |||
T40341 | SARS-CoV-2-IN-11 | Others | |
SARS-CoV-2-IN-11 is a highly potent and non-toxic inhibitor of the 3C-like protease (3CLpro) of SARS-CoV-2, demonstrating IC50 and EC50 values of 0.17 nM and 1.45 nM, respectively. This compound targets the essential vir... | |||
T38942 | SARS-CoV-2-IN-9 | Others | |
SARS-CoV-2-IN-9 is an inhibitor binding to subsites S1 and S2 in SARS-CoV-2 main protease. | |||
T40207 | SARS-CoV-2-IN-7 | Others | |
SARS-CoV-2-IN-7 demonstrates potent inhibition of viral replication in SARS-CoV-2-infected Vero E6 cells with an IC50 value of 844 nM. | |||
T12836 | SARS-CoV-2-IN-1 | Others | |
T60919 | SARS-CoV-2-IN-13 | SARS-CoV | |
SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide. SARS-CoV-2-IN-13 is more stable than niclosamide in human plasma and liver S9 enzymes assay. SARS-CoV-2-IN-13 can improve bioavailability and half-life when ad... | |||
T69535 | GRL-0820 | SARS-CoV-2-IN-6 | SARS-CoV |
GRL-0820 (SARS-CoV-2-IN-6) is a potent SARS-CoV-2 3CLpro inhibitor that can be used to study novel coronavirus infections. | |||
T63098 | SARS-CoV-2 Mpro-IN-2 | SARS-CoV | |
SARS-CoV-2 Mpro-IN-2 is a selective SARS-CoV-2M pro inhibitor with an IC50 value of 0.40 μM.SARS-CoV-2 Mpro-IN-2 has good antiviral activity and can be used to study COVID-19. | |||
T78961 | SARS-CoV-2-IN-38 | SARS-CoV | |
SARS-CoV-2-IN-38 is an orally available SARS-CoV-2 inhibitor with potential antiviral activity for the study of SARS viral infections. | |||
T62413 | SARS-CoV-2 nsp13-IN-1 | Antiviral | |
SARS-CoV-2 nsp13-IN-1 is an nsp13 with antiviral activity that inhibits the nsp13 ssDNA+ATPase, which can be used in the study of COVID-19 virus infection. | |||
T79659 | SARS-CoV-2 3CLpro-IN-16 | SARS-CoV | |
SARS-CoV-2 3CLpro-IN-16 is a covalent SARS-CoV-2 3CLpro inhibitor that inhibits 3CLpro activity and achieves its inhibitory effect by forming a covalent bond with Cys145. | |||
T62834 | SARS-CoV-2-IN-22 | Others | |
SARS-CoV-2-IN-22 is a SARS-CoV-2 pseudovirus inhibitor (IC50: 16.96 μM). | |||
T64184 | SARS-CoV-2-IN-8 | Others | |
SARS-CoV-2-IN-8 is a major protease inhibitor of SARS-CoV-2 (IC50: 0.75 μM). | |||
T60556 | SARS-CoV-2-IN-16 | Others | |
SARS-CoV-2-IN-16 (Compound 12) is a potent inhibitor of SARS-CoV-2 nucleocapsid protein (NPro) with potent antiviral activity (EC50 = 3.69 μM). SARS-CoV-2-IN-16 binds to NPro with a low Kd value of 7.82 μM, which suggest... | |||
T60962 | SARS-CoV-2-IN-18 | Others | |
SARS-CoV-2-IN-18 (Compound 26) is a potent inhibitor of SARS-CoV-2 3C-like protease (IC50 = 45 nM) [1]. | |||
T79243 | SARS-CoV-2-IN-43 | SARS-CoV | |
Compound 8h, also known as SARS-CoV-2-IN-43, is a powerful inhibitor effective in obstructing the replication of SARS-CoV-2, exhibiting significant antiviral activity [1]. | |||
T61613 | SARS-CoV-2-IN-17 | Others | |
SARS-CoV-2-IN-17 (Compound 16) is a highly effective inhibitor of SARS-CoV-2 nucleocapsid protein (NPro). It demonstrates potent anti-viral activity, with an EC50 value of 2.18 μM. Furthermore, SARS-CoV-2-IN-17 binds to ... | |||
T63694 | SARS-CoV-2-IN-33 | Others | |
SARS-CoV-2-IN-33 is an inhibitor of COVID-19. SARS-CoV-2-IN-3 exhibits good binding affinity (-8.0 Kcal/mole) for COVID-19 major protease (Mpro) (PDB ID: 6LU7). SARS-CoV-2-IN-33 exhibits good anti-proliferative effects o... | |||
T81205 | SARS-CoV-2-IN-66 | SARS-CoV | |
SARS-CoV-2-IN-66 (1), a derivative of vitamin K, functions as an inhibitor of SARS-CoV-2, exhibiting an effective concentration (EC50) of 70.8 μM in VeroE6/TMPRSS2 cells [1]. | |||
T81202 | SARS-CoV-2-IN-69 | SARS-CoV | |
SARS-CoV-2-IN-69 (Compound 7E) is a potent, non-covalent inhibitor of the SARS-CoV-2 main protease (M^pro) with an EC50 of 7.4 μM and also inhibits the papain-like protease (PL^pro) [1]. | |||
T76270 | SARS-CoV-2-IN-34 | ||
SARS-CoV-2-IN-34 (S-20-1) is a broad-spectrum pan-coronavirus (CoV) fusion inhibitor capable of penetrating the blood-brain barrier and demonstrating extensive inhibitory activity against both pseudotyped and authentic S... | |||
T63181 | SARS-CoV-2-IN-32 | Others | |
SARS-CoV-2-IN-32 is a COVID-19 inhibitor. SARS-CoV-2-IN-32 exhibits good binding affinity (-8.8 Kcal/mole) for the COVID-19 major protease (Mpro) (PDB ID: 6LU7) and has anti-proliferative effects on cancer cells. IN-32 c... | |||
T74946 | SARS-CoV-2-IN-28 | Others | |
SARS-CoV-2-IN-28, a two-armed diphosphate ester featuring a C7 alkyl chain and molecular tweezers of extended length, demonstrates antiviral properties by exhibiting IC 50 values of 0.4 μM against SARS-CoV-2 activity and... | |||
T74945 | SARS-CoV-2-IN-27 | Others | |
SARS-CoV-2-IN-27, a diphosphate ester featuring a C6 alkyl chain and extended-length molecular tweezers, demonstrates antiviral efficacy, with IC50 values of 1.0 μM and 1.7 μM against SARS-CoV-2 activity and spike pseudo... | |||
T78765 | SARS-CoV-2-IN-51 | SARS-CoV | |
SARS-CoV-2-IN-51 (S-10), a lead compound for Omicron fusion inhibition, demonstrates potent activity against Omicron and other SARS-CoV-2 variants, with EC50 values ranging from 0.82-5.45 μM. It functions by directly int... | |||
T79310 | SARS-CoV-2-IN-53 | SARS-CoV | |
ARS-CoV-2-IN-53 (Compd 5d) exhibits an inhibitory effect on SARS-CoV-2 replication, with an effective concentration (EC50) value of 14.3 μM, and demonstrates notable antiviral activity against human coronavirus 229E (HCo... | |||
T63950 | SARS-CoV-2-IN-19 | Others | |
SARS-CoV-2-IN-19 is a potent inhibitor of SARS-CoV-2 (EC50: 8.8 μM). SARS-CoV-2-IN-19 is effective against SARS-CoV-2 decapping enzyme (nsp13), a highly conserved enzyme that exhibits potential against emerging HCoV outb... | |||
T60785 | SARS-CoV-2-IN-6 | Others | |
SARS-CoV-2-IN-6 is an inhibitor of SARS-CoV-2 3CLpro with the IC 50 value of 73 nM. | |||
T81204 | SARS-CoV-2-IN-67 | SARS-CoV | |
SARS-CoV-2-IN-67 (Compound 16), a derivative of vitamin K, exhibits anti-SARS-CoV-2 properties, with an effective concentration (EC50) of 64.8 μM in VeroE6/TMPRSS2 cells, and inhibits SARS-CoV-2 RdRp activity [1]. | |||
T79227 | SARS-CoV-2-IN-49 | SARS-CoV | |
SARS-CoV-2-IN-49 acts as an irreversible covalent inhibitor targeting the main protease of SARS-CoV-2 [1]. | |||
T60841 | SARS-CoV-2-IN-23 | Others | |
SARS-CoV-2-IN-23 (compound GRL-0617) is an inhibitor of SARS-COV-2 papain-like protease (PLpro) (IC 50 = 2.3 μM) [1]. | |||
T62958 | SARS-CoV-2-IN-31 | Others | |
SARS-CoV-2-IN-31 is a potent inhibitor of COVID-19. SARS-CoV-2-IN-31 shows excellent to mild activity (IC50: 28.84-38.36 μM) against a variety of cancer cell lines. SARS-CoV-2-IN-31 can be used in cancer research. | |||
T74943 | SARS-CoV-2-IN-25 | Others | |
SARS-CoV-2-IN-25 (Compound CP026) is a potent inhibitor, specifically targeting the transduction of SARS-CoV-2 spike pseudoparticles, with an inhibitory concentration (IC50) of 1.6 μM. It effectively inhibits enveloped v... | |||
T81203 | SARS-CoV-2-IN-68 | SARS-CoV | |
SARS-CoV-2-IN-68 (compound 6C) is a covalent inhibitor of both SARS-CoV-2 PLpro and Mpro, exhibiting potent antiviral properties by targeting the Zn-finger domain of PLpro [1]. | |||
T78926 | SARS-CoV-2-IN-42 | SARS-CoV | |
SARS-CoV-2-IN-42 (Compound 8q) effectively inhibits SARS-CoV-2 replication with an EC50 value of 0.4 μM and demonstrates no significant toxicity to the host cell [1]. | |||
T81209 | SARS-CoV-2-IN-62 | SARS-CoV | |
SARS-CoV-2-IN-62 (Compound R3b) effectively inhibits SARS-CoV-2 replication in Vero E6 and Calu-3 cells, demonstrating low cytotoxicity and EC50 values of 2.97 μM and 3.82 μM, respectively [1]. | |||
T79244 | SARS-CoV-2-IN-44 | SARS-CoV | |
SARS-CoV-2-IN-44, an inhibitor of SARS-CoV-2, effectively suppresses viral replication with an EC50 value of 0.6μM and exhibits negligible cytotoxicity in Calu-3 cells, rendering it suitable for antiviral research [1]. | |||
T81208 | SARS-CoV-2-IN-63 | SARS-CoV | |
SARS-CoV-2-IN-63 (Compound R3e) serves as an inhibitor of SARS-CoV-2 replication, demonstrating low cytotoxicity. It effectively suppresses viral replication within Vero E6 cells and Calu-3 cells, yielding half-maximal e... | |||
T79356 | SARS-CoV-2-IN-57 | Sigma receptor | |
SARS-CoV-2-IN-57 (compound (+)-R-26) is a potent inhibitor of SARS-CoV-2 with an IC50 of 80 nM and demonstrates high affinity for the Sigma Receptor, exhibiting Kis of 13.6 nM (S1R) and 14.4 nM (S2R) [1]. | |||
T60271 | SARS-CoV-2 nsp3-IN-2 | Others | |
SARS-CoV-2 nsp3-IN-2 is a SARS-CoV-2 nsp3 macrodomain (Mac1) inhibitor with IC 50 value of 180 μM. SARS-CoV-2 nsp3 macrodomain is an ADP-ribosylhydrolase that is critical for coronavirus replication and pathogenesis. SAR... | |||
T62819 | SARS-CoV-2 nsp14-IN-2 | Others | |
SARS-CoV-2 nsp14-IN-2 is a potent inhibitor of SARS-CoV-2 Nsp14 methyltransferase (IC50: 0.093 μM). SARS-CoV-2 nsp14-IN-2 has the potential to be used in COVID-19 studies. | |||
T63385 | SARS-CoV-2 3CLpro-IN-2 | Others | |
SARS-CoV-2 3CLpro-IN-2 is a potent inhibitor of the 3CL protease pair and has shown research potential for SARS-CoV-2 disease. | |||
T62264 | SARS-CoV-2 nsp13-IN-2 | Others | |
SARS-CoV-2 nsp13-IN-2 (Compound C2) is a small molecule inhibitor of SARS-CoV-2 non-structural protein 13 (nsp13) that acts on nsp13 ssDNA+ATPase (IC50: 42 μM). | |||
T63292 | SARS-CoV-2-IN-24 | Others | |
SARS-CoV-2-IN-24 is a potent inhibitor of papain-like proteases (PLpro) that induces conformational changes in SARS-COV-2 papain-like proteases, inhibits SARS-COV-2 replication, and can be used to study SARS-CoV-2. |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T72581 | SARS-CoV MPro-IN-2 | Others | |
SARS-CoV MPro-IN-2 effectively inhibits the SARS-CoV-2 main protease (M pro), crucial for the virus's replication and transcription in host cells, with an IC50 value of 72.07 nM. Given its significant role in processing ... | |||
T8689 | Chloroquine | CQ | SARS-CoV , TLR , HIV Protease , Antibiotic , Parasite , Autophagy |
Chloroquine is a Toll-like receptor inhibitor that inhibits autophagy. Chloroquine has anti-malarial and anti-inflammatory activity and is widely used in the treatment of malaria and rheumatoid arthritis. Chloroquine als... | |||
TN3651 | Cichoriin | Others | |
Cichoriin is a photosensitive compound, it could be used as herbal photosensitizing agent in treating benign breast tumor in rats. | |||
T2869 | Emodin | Frangula emodin | SARS-CoV , Casein Kinase , Autophagy |
Emodin (Frangula emodin) is a naturally occurring anthraquinone present in the roots and barks of numerous plants; exerts antiproliferative effects in Y cells that are regulated by different signaling pathways. | |||
T2563 | Acetyl-L-carnitine hydrochloride | Acetyl L-carnitine hydrochloride,O-Acetylcarnitine,O-acetyl-L-carnitine,O-Acetyl-L-carnitine hydrochloride | Others , Endogenous Metabolite |
Acetyl-L-carnitine hydrochloride (Acetyl L-carnitine hydrochloride) is a nutritional supplement composed of the hydrochloride salt form of the acetylated form of the endogenously produced L-carnitine, with potential neur... | |||
T21883 | Gedunin | HSP | |
Gedunin is an important limonoid present in several genera of the Meliaceae family, mainly in seeds. Gedunin is an Hsp90 inhibitor, and inhibits ovarian cancer cell proliferation. | |||
T6670 | Silymarin | Silybin B | SARS-CoV |
Silymarin (Silybin B) (Silybin B) is a polyphenolic flavonoid that extracts from the milk thistle or seeds of Silybum marianum. It is used in the prevention and treatment of liver diseases. | |||
T79947 | 10-Hydroxyaloin A | SARS-CoV | |
Hydroxyaloin A (10-10-Hydroxyaloin A) is a potent inhibitor of SARS-CoV-2, demonstrating significant efficacy in binding to the active site of the SARS-CoV-2 main protease (M^pro) [1]. | |||
T80010 | (25S)-Antcin B | SARS-CoV | |
Antcin-B exhibits a high-affinity inhibition of 3CLPro, which is potentially significant in SARS-CoV-2 research [1]. | |||
T73900 | (±)-Alliin | Others | |
(±)-Alliin, the principal active component in garlic, functions as a potential inhibitor of SARS-CoV-2's main protease (Mpro) [1]. |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPY-06071 | SARS-CoV-2 RNA-dependent RNA polymerase/RDRP Protein (His) | SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 RNA-dependent RNA polymerase/RDRP Protein (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 108.3 kDa and the accession number is YP_009725307.1. | |||
TMPY-05679 | SARS-CoV-2 Spike RBD Protein (hFc) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (hFc) is expressed in HEK293 mammalian cells. The predicted molecular weight is 51.8 kDa and the accession number is A0A6G7K2L4. | |||
TMPK-00265 | SARS-COV-2 Nucleocapsid Protein (His & Avi), Biotinylated | SARS-CoV-2 | E. coli |
Nucleocapsid protein (N) is the major viral structural component; its main function is to protect and encapsidate the viral RNA forming viral RNP complex. It is encoded by the S segment vRNA and is abundantly expressed i... | |||
TMPY-05661 | SARS-CoV-2 Spike S1 Protein (HEK293, His) | HEK293 Cells | |
SARS-CoV-2 Spike S1 Protein (HEK293, His) is expressed in HEK293 mammalian cells with His tag. The accession number is A0A6G7K2L4. | |||
TMPY-05664 | SARS-CoV-2 Nucleocapsid Protein (His) | SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 Nucleocapsid Protein (His) is expressed in Baculovirus insect cells. The predicted molecular weight is 47.08 kDa and the accession number is P0DTC9. | |||
TMPY-06042 | SARS-CoV-2 Spike RBD Protein (N481D, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (N481D, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05978 | SARS-CoV-2 Spike RBD Protein (S359N, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (S359N, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05703 | SARS-CoV-2 Spike RBD Protein (K458R, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (K458R, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.53 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06086 | SARS-CoV-2 Helicase Protein (His) | SARS-CoV-2 | E. coli |
SARS-CoV-2 Helicase Protein (His) is expressed in E. coli expression system. The predicted molecular weight is 67.8 kDa and the accession number is YP_009725308.1. | |||
TMPY-06043 | SARS-CoV-2 Spike RBD Protein (F456L, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (F456L, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05723 | SARS-CoV-2 Spike S1 Protein (D614G, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike S1 Protein (D614G, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 76.41 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06041 | SARS-CoV-2 Spike RBD Protein (K458Q, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (K458Q, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05751 | SARS-CoV-2 Spike RBD Protein (W436R, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (W436R, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.51 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05959 | SARS-CoV-2 Spike RBD Protein (V341I, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (V341I, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05976 | SARS-CoV-2 Spike RBD Protein (T478I, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (T478I, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06065 | SARS-CoV-2 Spike RBD Protein (A475V, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (A475V, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05979 | SARS-CoV-2 Spike RBD Protein (K378R, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (K378R, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05980 | SARS-CoV-2 Spike RBD Protein (Q409E, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (Q409E, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05962 | SARS-CoV-2 Spike RBD Protein (V503F, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (V503F, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06068 | SARS-CoV-2 Spike RBD Protein (N501Y, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (N501Y, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06073 | SARS-CoV-2 Spike RBD Protein (N487R, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (N487R, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06045 | SARS-CoV-2 Spike RBD Protein (F456E, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (F456E, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06072 | SARS-CoV-2 Spike RBD Protein (L455F, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (L455F, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05969 | SARS-CoV-2 Spike RBD Protein (Q414E, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (Q414E, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05982 | SARS-CoV-2 Spike RBD Protein (A372T, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (A372T, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05695 | SARS-CoV-2 Nucleocapsid Protein (His), Biotinylated | SARS-CoV-2 | Baculovirus Insect Cells |
SARS-CoV-2 Nucleocapsid Protein (His), Biotinylated is expressed in Baculovirus insect cells. The predicted molecular weight is 47.08 kDa and the accession number is P0DTC9. | |||
TMPY-06070 | SARS-CoV-2 Spike RBD Protein (F490L, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (F490L, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05960 | SARS-CoV-2 Spike RBD Protein (Y508H, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (Y508H, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06047 | SARS-CoV-2 Spike RBD Protein (G446S, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (G446S, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06046 | SARS-CoV-2 Spike RBD Protein (F486S, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (F486S, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05698 | SARS-CoV-2 Spike RBD Protein (V367F, mFc) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (V367F, mFc) is expressed in HEK293 mammalian cells. The predicted molecular weight is 51.54 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05990 | SARS-CoV-2 Spike RBD Protein (S477I, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (S477I, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06084 | SARS-CoV-2 Spike RBD Protein (E484K, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (E484K, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05961 | SARS-CoV-2 Spike RBD Protein (N439K, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (N439K, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05974 | SARS-CoV-2 Spike RBD Protein (L452R, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (L452R, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05694 | SARS-CoV-2 Spike S1 Protein (His), Biotinylated | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike S1 Protein (His), Biotinylated is expressed in HEK293 mammalian cells. The predicted molecular weight is 76.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06002 | SARS-CoV-2 Spike RBD Protein (K417N, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (K417N, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05993 | SARS-CoV-2 Spike RBD Protein (T393P, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (T393P, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06000 | SARS-CoV-2 Spike RBD Protein (P479S, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (P479S, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05958 | SARS-CoV-2 Spike RBD Protein (R408I, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (R408I, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06050 | SARS-CoV-2 Spike RBD Protein (Y453F, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (Y453F, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05984 | SARS-CoV-2 Spike RBD Protein (A520V, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (A520V, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05970 | SARS-CoV-2 Spike RBD Protein (P384L, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (P384L, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06005 | SARS-CoV-2 Spike RBD Protein (S477R, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (S477R, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06096 | SARS-CoV-2 Nucleocapsid Protein (P13L, His) | SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (P13L, His) is expressed in E. coli expression system. The predicted molecular weight is 46.6 kDa and the accession number is P0DTC9. | |||
TMPY-05663 | SARS-CoV-2 Spike RBD Protein (mFc) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (mFc) is expressed in HEK293 mammalian cells. The predicted molecular weight is 51.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05994 | SARS-CoV-2 Spike RBD Protein (V395I, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (V395I, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.6 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-06098 | SARS-CoV-2 Nucleocapsid Protein (I292T, His) | SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (I292T, His) is expressed in E. coli expression system. The predicted molecular weight is 46.6 kDa and the accession number is P0DTC9. | |||
TMPY-05986 | SARS-CoV-2 Spike RBD Protein (F490S, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (F490S, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.5 kDa and the accession number is A0A6G7K2L4. | |||
TMPY-05966 | SARS-CoV-2 Spike RBD Protein (A520S, His) | SARS-CoV-2 | HEK293 Cells |
SARS-CoV-2 Spike RBD Protein (A520S, His) is expressed in HEK293 mammalian cells. The predicted molecular weight is 26.57 kDa and the accession number is A0A6G7K2L4. | |||
------------------------ More ------------------------ |
カタログ番号 | 製品名 | ||
---|---|---|---|
L1710 | Anti-COVID-19 Compound Library | 1133 compounds | |
A unique collection of 1133 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents; |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
TMIH-0146 | Chloroquine-d5 | ||
Chloroquine-d5 is a deuterated compound of Chloroquine. Chloroquine has a CAS number of 54-05-7. Chloroquine is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine is an antimalarial and anti-inflammatory ... | |||
T38297 | Ribavirin-13C5 | Ribavirin-13C5 | |
Ribavirin-13C5is intended for use as an internal standard for the quantification of ribavirin by GC- or LC-MS. Ribavirin is an antiviral guanosine nucleoside analog.1,2Upon entry into cells, ribavirin is metabolized to a... |